Novel therapeutic targets for cholestatic and fatty liver disease

Cholestatic and non-alcoholic fatty liver disease (NAFLD) share several key pathophysiological mechanisms which can be targeted by novel therapeutic concepts that are currently developed for both areas. Nuclear receptors (NRs) are ligand-activated transcriptional regulators of key metabolic processe...

Descripción completa

Detalles Bibliográficos
Autores principales: Trauner, Michael, Fuchs, Claudia Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Recent Advances in Clinical Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666813/
https://www.ncbi.nlm.nih.gov/pubmed/34615727
http://dx.doi.org/10.1136/gutjnl-2021-324305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666813/
https://www.ncbi.nlm.nih.gov/pubmed/34615727
http://dx.doi.org/10.1136/gutjnl-2021-324305

Ejemplares similares